Lineage Cell Therapeutics
LCTX
#8906
Rank
ยฃ0.14 B
Marketcap
ยฃ0.59
Share price
-5.87%
Change (1 day)
-55.60%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2026 (TTM): -ยฃ0.20

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.21. In 2019 the company made an earnings per share (EPS) of -ยฃ0.03058 an increase over its 2018 EPS that were of -ยฃ0.27.

EPS history for Lineage Cell Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.20
2019-ยฃ0.03058-88.57%
2018-ยฃ0.27
2016ยฃ0.24
2014-ยฃ0.43
2012-ยฃ0.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA